CD4 and cancer: It was found that the expression of NALCN was significantly associated with CD8+ T cells infiltration level among 14 cancer types, CD4+ T cells among 17 cancer types, neutrophil among 16 cancer types, DCs among 19 cancer types, macrophages among 19 cancer types, and B cells among 5 cancer types (Figure 8B).